INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 204 filers reported holding INSMED INC in Q3 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $87,019,934 | +32.6% | 3,446,334 | +10.8% | 4.70% | +34.0% |
| Q2 2023 | $65,606,947 | +31.2% | 3,109,334 | +6.0% | 3.51% | +66.1% |
| Q1 2023 | $49,992,953 | -0.7% | 2,932,138 | +16.3% | 2.11% | -0.2% |
| Q4 2022 | $50,367,602 | +90.0% | 2,520,901 | +104.8% | 2.12% | +92.2% |
| Q3 2022 | $26,511,000 | -35.3% | 1,230,800 | -40.8% | 1.10% | -29.4% |
| Q2 2022 | $40,992,000 | +32.3% | 2,078,680 | +57.7% | 1.56% | +64.8% |
| Q1 2022 | $30,983,000 | +5.2% | 1,318,432 | +21.9% | 0.95% | +66.0% |
| Q4 2021 | $29,461,000 | +7.1% | 1,081,532 | +8.3% | 0.57% | +23.1% |
| Q3 2021 | $27,505,000 | +119.1% | 998,732 | +126.4% | 0.46% | +146.3% |
| Q2 2021 | $12,553,000 | +11.8% | 441,065 | +30.8% | 0.19% | +17.5% |
| Q4 2020 | $11,224,000 | +3.6% | 337,145 | 0.0% | 0.16% | -17.9% |
| Q3 2020 | $10,836,000 | -56.1% | 337,145 | -62.4% | 0.20% | -63.2% |
| Q2 2020 | $24,664,000 | +2209.4% | 895,560 | +1244.7% | 0.53% | +1727.6% |
| Q1 2020 | $1,068,000 | – | 66,600 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
| Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
| Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
| MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
| Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
| Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
| GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
| Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
| SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |